News
Crossed
Your contact person

Jan Phillip Denkers
PR & Communications Manager
T +49.40.593 62 61-23
E-Mail

Filter reset
The facility employs J.POD® technology that uses autonomous clean rooms to run small, highly intensified production processes, thereby reducing the cost of biologics manufacturing. (Picture: ©Benjamin Benschneider)

Biotech & Pharma

Just - Evotec Biologics opens J.POD® 1 US

Evotec SE announced the opening of the company’s late-stage clinical and commercial biologics cGMP manufacturing facility (J.POD® 1 US) in Redmond, Washington. The innovative cGMP biomanufacturing …
Funds to be used to obtain clinical proof of concept in two programs and to accelerate innovative pipeline focused on restoring immune tolerance to treat and potentially cure autoimmune diseases (Picture: ©Topas Therapeutics)

Biotech & Pharma, Research, Academia & Universities

Topas Therapeutics Extends Series B

Topas Therapeutics GmbH (Topas), a private biotechnology company developing immune tolerance-inducing drugs to treat and potentially cure a variety of autoimmune diseases, today announced that the …
Evotec creates further opportunities for long-term growth with "Campus Levi-Montalcini" in Verona. (Picture: ©Z S / Unsplash)

Biotech & Pharma

Evotec creates long-term growth opportunities

Evotec SE announced that Evotec has added significant opportunities for further, long-term growth by acquiring the Verona site from GlaxoSmithKline SpA (“GSK”). During a site meeting, the employees …
From left to right: Robert Feidenhans'l, Nicole Elleuche, Friederike Kampschulte, Katharina Fegebank. (Picture: ©European XFEL / Axel Heimken)

Forschung & Hochschulen 

New accommodation for XFEL's global researchers

Katharina Fegebank, Senator for Research, Science and Equality in Hamburg, and Friederike Kampschulte, Head of the Science Department at the Ministry of Education, Science and Culture in …
How do virus variants arise and how do they spread? (Picture: ©CDC/ Alissa Eckert, MSMI; Dan Higgins, MAMS)

Research, Academia & Universities

Why are alpha and delta faster than wild type?

How do virus variants arise and how do they spread? This is one of the key questions of a new research project initiated jointly by researchers at the Leibniz Institute for Experimental Virology (HPI) …
Fraunhofer ITMP uses high-tech methods for cell-based drug screening. (Picture: ©Fraunhofer ITMP)

Biotech & Pharma, LSN (EN)

Stem Cell-Based Translation

The North as a hub for global stem cell research: The 2021 Annual Meeting of the International Society for Stem Cell Research (ISSCR) was scheduled to take part from June 23 to 26. The event, which …
In addition to climate protection, funding schemes in Hamburg should also find their way into the fields of life science, infection and pandemic control, and digitalization. (Picture: ©Mediaserver Hamburg/Timo Sommer)

Digitalisation, Funding & Competition

EUR 30 million in EU funds for projects in Hamburg

The European Commission has approved the use of EUR 30 million in funds for climate protection and innovation funds in Hamburg through 2023 as part of the REACT-EU scheme, the Ministry of Economics …
Dr. Tanmay Bharat, Sir William Dunn School of Pathology, University of Oxford (Picture: ©Eppendorf AG)

Biotech & Pharma, Research, Academia & Universities

Eppendorf Award for Young European Investigators 2021

In 2021, Eppendorf AG, the Hamburg life sciences company, is presenting its highly prestigious research prize for the 26th time. The independent Eppendorf Award Jury chaired by Prof. Reinhard Jahn …
May 26, 2021, is the effective date of the new EU regulation, which came into force four years ago. (Picture: ©Miriam Barton)

LSN (EN)

How to master the MDR challenge

How medical technology companies in the North succeed to deal with the new requirements of the Medical Device Regulation – even in uncertain times and pandemic circumstances.

MedTech

Sysmex supports healthcare workers in fighting the pandemic

Sysmex Europe GmbH announces the launch of the HISCL™-5000 fully automated random-access immunochemistry analyser and the HISCL™ SARS-CoV-2 Ag Assay Kit in the EMEA region.

MedTech

Sysmex obtains the first IVDR certification

Sysmex Europe GmbH announced that LYNOAMP CK19 E [1], part of OSNATM [2] method using a molecular biological technique for cancer diagnostics, is the first Sysmex product to be certified by a notified …
Indivumed is using nRavel™ for target discovery and drug development programs. (Picture: ©Jackie Niam/stock.adobe.com)

Biotech & Pharma, Digitalisation

Indivumed Launches the nRavel AI Platform

Indivumed GmbH (“Indivumed”) today announced the launch of nRavel™, a unique AI discovery platform for oncology and precision medicine. The platform combines IndivuType’s deep multi-omics data with …